Apalutamide for patients with metastatic castration-sensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial

Ethnicity might be associated with treatment outcomes in advanced prostate cancer. This study aimed to evaluate the efficacy and safety of androgen deprivation therapy (ADT) combined with apalutamide in East Asians with metastatic castration-sensitive prostate cancer (mCSPC). The original phase 3 Ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Byung Ha, Huang, Jian, Ye, Zhang-Qun, He, Da-Lin, Uemura, Hirotsugu, Arai, Gaku, Kim, Choung Soo, Zhang, Yuan-Yuan, Koroki, Yusoke, Jeong, SuYeon, Mundle, Suneel, Triantos, Spyros, McCarthy, Sharon, Chi, Kim N, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887099/
https://www.ncbi.nlm.nih.gov/pubmed/34259202
http://dx.doi.org/10.4103/aja.aja_64_21

Ejemplares similares

Ejemplares similares